The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 29, 2025

Filed:

Mar. 22, 2023
Applicant:

Corcept Therapeutics, Inc., Menlo Park, CA (US);

Inventors:

Hazel Hunt, Storrington, GB;

Thaddeus S. Block, Menlo Park, CA (US);

Assignee:

Corcept Therapeutics, Inc., Redwood City, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/416 (2006.01); A61K 31/03 (2006.01); A61K 31/18 (2006.01); A61K 31/337 (2006.01); A61K 31/4192 (2006.01); A61K 31/44 (2006.01); A61K 31/473 (2006.01); A61K 31/513 (2006.01); A61K 31/7068 (2006.01); A61K 33/243 (2019.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
A61K 31/416 (2013.01); A61K 31/03 (2013.01); A61K 31/18 (2013.01); A61K 31/337 (2013.01); A61K 31/4192 (2013.01); A61K 31/44 (2013.01); A61K 31/473 (2013.01); A61K 31/513 (2013.01); A61K 31/7068 (2013.01); A61K 33/243 (2019.01); A61K 45/06 (2013.01);
Abstract

Methods and compositions for treating a subject hosting a non-ACTH-secreting pancreatic tumor are disclosed. The methods include administering to the subject a chemotherapeutic agent and a glucocorticoid receptor modulator (GRM), preferably a selective glucocorticoid receptor modulator (SGRM), to reduce the tumor load in the subject. The non-ACTH-secreting pancreatic tumor may be an exocrine pancreatic tumor. The GRM may be a nonsteroidal GRM or a nonsteroidal SGRM. The nonsteroidal SGRM may be a nonsteroidal compound comprising: a fused azadecalin structure; a heteroaryl ketone fused azadecalin structure; or an octahydro fused azadecalin structure. Pharmaceutical compositions comprising a chemotherapeutic agent and a GRM are disclosed. The GRM in such pharmaceutical compositions may be a nonsteroidal GRM, and may be a nonsteroidal SGRM. The nonsteroidal SGRM may comprise: a fused azadecalin structure; a heteroaryl ketone fused azadecalin structure; or an octahydro fused azadecalin structure.


Find Patent Forward Citations

Loading…